SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page7891011121314Next Page
2026-05-28EVMN144GREGORY MOSS plan to sell securities of Evommune, Inc. under Form 144MEDIUM
GREGORY MOSS filed Form 144 to notify SEC of plan to sell 14223 units of Evommune, Inc. securities around 2026-05-28, with aggregate market value of $331,964.82. The total outstanding units is 36018372.0. The amount planned to be sold represents 0.04% of total outstanding units; ...
Small CapBiotechnology
Previous Page7891011121314Next Page